Clinical Trial Update: Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study

View source ↗

Summary

A multi-center clinical trial update evaluating the resectability of pancreatic head cancer using contrast-enhanced MDCT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Meng Su Zeng | Conditions: Adenocarcinoma of Head of Pancreas | Status: UNKNOWN